The president of Mexico, Andrés Manuel López Obrador, reported this Thursday that his government has just authorized 180 million pesos (almost 9 million dollars) to advance the research and development of Patria, the Mexican vaccine against covid-19.
“Research is already being done in Mexico, and it is going very well, on the Patria vaccine. We are going to have our vaccine, we are working for thatHe has all the support, “said the Mexican president in his morning conference, where he announced that at the moment” all the analyzes “are being carried out to determine the efficacy of the drug.
López Obrador stressed that when it is ready it is vaccinated, developed by the National Council of Science and Technology (Conacyt), the immunization campaign against covid-19 in Mexico will be much easierIt will not depend on foreign pharmaceutical companies, which, in his opinion, have interests and aspire that countries are always “buying and buying vaccines.”
Last April —when the vaccine was about to begin Phase I of human trials—, the head of Conacyt, María Elena Álvarez-Buylla, reported that Patria uses the Newcastle disease virus, which is not harmful and has been used in the Mexican laboratory Avimex for more than 15 years.
For his part, Dr. Constantino III Roberto López Macías, one of the scientists who heads the development of the Mexican vaccine, also commented that Patria would be part of “a second generation of coronavirus vaccines “.
How does it work?
Like other vaccines that are already on the market, Patria generates antibodies from the encoding protein S, the spike-shaped envelope of the virus that facilitates the entry of SARS-CoV-2 into cells:
- The vector carries a gene encoding the SARS-CoV-2 protein S.
- The cell produces SARS-CoV-2 protein S.
- The immune system produces antibodies against protein S.
An advantage that this drug would have is that is put to the test among the different variants of the coronavirus, which would allow it to have a broad capacity to immunize the different mutations.
Vaccination of minors
On the other hand, López Obrador announced that his government will challenge the order to vaccinate minors between the ages of 12 and 17, issued on Wednesday by the Seventh District Court of the State of Mexico, since it is not final and must be approved by other instances.
“It is not that they do not want to apply the vaccine to minors here, it is that there is no medical recommendation in that sense, they have not yet defined, because they can cause harm. So, we have to wait, I have explained it many times“, said the president.
On the other hand, López Obrador insisted on the need for the World Health Organization to speed up the procedures for the approval of other vaccines that have shown effectiveness in different countries and in millions of people, without presenting serious reactions, as is the case of Sputnik V and Cansino.
In addition, the Mexican president reported that his Government has arranged more than 40,000 million pesos (almost 2,000 million dollars) for the purchase of vaccines against covid-19 that are applied in the immunization campaign in the country, which is already approaching. the 50 million people vaccinated with two doses and the 67 million with one.
Disclaimer: This article is generated from the feed and not edited by our team.